All blog items

Research Community News iRIS/OnCore Updates DOCR News Did You Know? Training Opportunities Clinical Research Employee Highlights Partner Resources iRIS/OnCore Office Hours July 15 | 11 am | DMP 2W91 July 29 | 11 am | DMP 2W91 August 12 | 11 am | DMP 2W91 August 26 | 11 am | DMP 2W91

Thursday, September 19, 2019 1:00-3:30pm; Trent Semans Great Hall Register here  

In 2015, the School of Medicine and Pratt School of Engineering, with support from the Office of the Provost, created MEDx. An initiative rather than an institute, MEDx is structured to enhance existing ties and encourage new collaborations among faculty from both schools as well as other schools, institutes and initiatives at Duke. This MEDx article is part of a series that highlights key leaders in medicine and their thoughts on the intersection of medicine and engineering.

Congratulations to the 24 School of Medicine and Duke Health faculty who graduated from the 2019 Duke Clinical Leadership Program (DCLP) last week! DCLP was founded by the Chancellor for Health Affairs in 2010 to help expand leadership capacity within Duke Health.

During the State of the School Address, the Dean reflected on the successes and challenges of the past year and shared her outlook for the future of the School of Medicine.

Beth Sullivan, PhD, Associate Professor of Molecular Genetics and Microbiology, has been named Associate Dean for Research Training for the Duke University School of Medicine, effective July 1, 2019.

About 250 Duke Faculty and staff learned and discussed the key features of the electronic system during the most recent Research Town Hall, hosted by DOSI on June 11 at the Trent Semans Great Hall

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing.   In breast cancer especially, only a small number of patients are even eligible to undergo treatment with immunotherapies, and most see little benefit.   But in a pre-clinical study led by the Duke Cancer Institute, researchers outlined a potential way to improve those results by uncloaking breast cancer tumors to the body’s immune system.   

The Division of Head and Neck Surgery & Communication Sciences within the Department of Surgery will be elevated to department status, effective July 1, 2019. The Duke University Health System Board of Directors approved the upgrade resolution on June 14, 2019. The upgrade proposal was approved by the Duke University Board of Trustees in May. Elevation from division to department signals the growth and independence of the division. Department status can enhance awareness and recognition nationally and can also aid in the ability to recruit faculty in the specialty. Dr.

James B. Wyngaarden, MD, professor emeritus and former chair of the Duke Department of Medicine as well as former director of the National Institutes of Health, died on June 14 at the age of 94. Dr. Wyngaarden was a towering figure in medicine and an exceptional leader at Duke. He was an internationally recognized authority on the regulation of purine biosynthesis and the genetics of gout and a nationally respected advocate for the role of physician-scientists in clinical investigations.